Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials von Mega, Jessica L, Dr, Stitziel, Nathan O, Dr, Smith, J Gustav, MD, Chasman, Daniel I, PhD, Caulfield, Mark J, Prof, Devlin, James J, PhD, Nordio, Francesco, PhD, Hyde, Craig L, PhD, Cannon, Christopher P, Prof, Sacks, Frank M, Prof, Poulter, Neil R, Prof, Sever, Peter S, Prof, Ridker, Paul M, Prof, Braunwald, Eugene, Prof, Melander, Olle, Prof, Kathiresan, Sekar, MD, Sabatine, Marc S, Prof

Volltext

Acute myocardial infarction von Reed, Grant W, MD, Rossi, Jeffrey E, MD, Cannon, Christopher P, Prof

Volltext

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes von Cannon, Christopher P, Pratley, Richard, Dagogo-Jack, Samuel, Mancuso, James, Huyck, Susan, Masiukiewicz, Urszula, Charbonnel, Bernard, Frederich, Robert, Gallo, Silvina, Cosentino, Francesco, Shih, Weichung J, Gantz, Ira, Terra, Steven G, Cherney, David Z.I, McGuire, Darren K

Volltext

Physiology. COX-2 inhibitors and cardiovascular risk von Cannon, Christopher P, Cannon, Paul J

Volltext

COX-2 Inhibitors and Cardiovascular Risk von Cannon, Christopher P., Cannon, Paul J.

Volltext

Acute Coronary Syndromes: Diagnosis and Management, Part I von Kumar, Amit, MD, Cannon, Christopher P., MD

Volltext

PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future von Shimada, Yuichi J, Cannon, Christopher P

Volltext

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODY... von Kereiakes, Dean J., MD, FACC, FSCAI, Robinson, Jennifer G., MD, MPH, Cannon, Christopher P., MD, Lorenzato, Christelle, MSc, Pordy, Robert, MD, Chaudhari, Umesh, MD, Colhoun, Helen M., MD, MFPHM, FRCP(Ed)

Volltext

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial von Fitchett, David, Inzucchi, Silvio E, Cannon, Christopher P, McGuire, Darren K, Scirica, Benjamin M, Johansen, Odd Erik, Sambevski, Steven, Kaspers, Stefan, Pfarr, Egon, George, Jyothis T, Zinman, Bernard

Volltext

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure von Bhatt, Deepak L, Szarek, Michael, Steg, P. Gabriel, Cannon, Christopher P, Leiter, Lawrence A, McGuire, Darren K, Lewis, Julia B, Riddle, Matthew C, Voors, Adriaan A, Metra, Marco, Lund, Lars H, Komajda, Michel, Testani, Jeffrey M, Wilcox, Christopher S, Ponikowski, Piotr, Lopes, Renato D, Verma, Subodh, Lapuerta, Pablo, Pitt, Bertram

Volltext

Colletotrichum – current status and future directions von Cannon, P.F., Damm, U., Johnston, P.R., Weir, B.S.

Volltext

The Colletotrichum acutatum species complex von Damm, U., Cannon, P.F., Woudenberg, J.H.C., Crous, P.W.

Volltext

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention von Bohula, Erin A., MD, DPhil, Morrow, David A., MD, MPH, Giugliano, Robert P., MD, SM, Blazing, Michael A., MD, He, Ping, MS, Park, Jeong-Gun, PhD, Murphy, Sabina A., MPH, White, Jennifer A., MS, Kesaniemi, Y. Antero, MD, PhD, Pedersen, Terje R., MD, PhD, Brady, Adrian J., MD, Mitchel, Yale, MD, Cannon, Christopher P., MD, Braunwald, Eugene, MD

Volltext

C-Reactive Protein Levels and Outcomes after Statin Therapy von Ridker, Paul M, Cannon, Christopher P, Morrow, David, Rifai, Nader, Rose, Lynda M, McCabe, Carolyn H, Pfeffer, Marc A, Braunwald, Eugene

Volltext

Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis von Arnott, Clare, Li, Qiang, Kang, Amy, Neuen, Brendon L., Bompoint, Severine, Lam, Carolyn S. P., Rodgers, Anthony, Mahaffey, Kenneth W., Cannon, Christopher P., Perkovic, Vlado, Jardine, Meg J., Neal, Bruce

Volltext

Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling von Vaduganathan, Muthiah, Sathiyakumar, Vasanth, Singh, Avinainder, McCarthy, Cian P., Qamar, Arman, Januzzi, James L., Scirica, Benjamin M., Butler, Javed, Cannon, Christopher P., Bhatt, Deepak L.

Volltext

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial von Jardine, Meg J., Zhou, Zien, Mahaffey, Kenneth W., Oshima, Megumi, Agarwal, Rajiv, Bakris, George, Bajaj, Harpreet S., Bull, Scott, Cannon, Christopher P., Charytan, David M., de Zeeuw, Dick, Di Tanna, Gian Luca, Greene, Tom, Heerspink, Hiddo J. L., Levin, Adeera, Neal, Bruce, Pollock, Carol, Qiu, Rose, Sun, Tao, Wheeler, David C., Zhang, Hong, Zinman, Bernard, Rosenthal, Norman, Perkovic, Vlado

Volltext

The Colletotrichum boninense species complex von Damm, U., Cannon, P.F., Woudenberg, J.H.C., Johnston, P.R., Weir, B.S., Tan, Y.P., Shivas, R.G., Crous, P.W.

Volltext

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease von Bowman, Louise, Hopewell, Jemma C, Chen, Fang, Wallendszus, Karl, Stevens, William, Collins, Rory, Wiviott, Stephen D, Cannon, Christopher P, Braunwald, Eugene, Sammons, Emily, Landray, Martin J

Volltext

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial von Murphy, Sabina A, Cannon, Christopher P, Blazing, Michael A, Giugliano, Robert P, White, Jennifer A, Lokhnygina, Yuliya, Reist, Craig, Im, KyungAh, Bohula, Erin A, Isaza, Daniel, Lopez-Sendon, Jose, Dellborg, Mikael, Kher, Uma, Tershakovec, Andrew M, Braunwald, Eugene

Volltext